These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of the Data and Safety Monitoring Committee (DSMC). Wilhelmsen L Stat Med; 2002 Oct; 21(19):2823-9. PubMed ID: 12325098 [TBL] [Abstract][Full Text] [Related]
4. The data monitoring experience in the MOXCON trial. Pocock S; Wilhelmsen L; Dickstein K; Francis G; Wittes J Eur Heart J; 2004 Nov; 25(22):1974-8. PubMed ID: 15541832 [TBL] [Abstract][Full Text] [Related]
7. ["Workshop on Data Monitoring Committee in NIH"--data monitoring in cancer clinical trial]. Sakamoto J; Nakazato H Gan To Kagaku Ryoho; 1992 Jul; 19(7):1099-104. PubMed ID: 1626947 [No Abstract] [Full Text] [Related]
8. [Interim analysis in clinical trials: a methodological guide]. Muñoz Navarro SR; Bangdiwala SI Rev Med Chil; 2000 Aug; 128(8):935-41. PubMed ID: 11129556 [TBL] [Abstract][Full Text] [Related]
9. The independent statistician for data monitoring committees. DeMets DL; Fleming TR Stat Med; 2004 May; 23(10):1513-7. PubMed ID: 15122729 [TBL] [Abstract][Full Text] [Related]
10. [Policies for clinical trials in cancer]. Suemasu K Gan No Rinsho; 1988 Jan; 34(1):7-12. PubMed ID: 3339851 [TBL] [Abstract][Full Text] [Related]
11. The other side of clinical trial monitoring; assuring data quality and procedural adherence. Williams GW Clin Trials; 2006; 3(6):530-7. PubMed ID: 17170037 [TBL] [Abstract][Full Text] [Related]
12. [Monitoring the safety of participants in randomised clinical trials: basis and methods]. Tijssen JG Ned Tijdschr Geneeskd; 2008 Mar; 152(12):674-8. PubMed ID: 18438062 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacy Department standard procedures for clinical trial development]. Pérez Peiró C; Porta Oltra B; Cholvi Llovell M; Jiménez Torres NV Farm Hosp; 2004; 28(1):36-47. PubMed ID: 15012177 [TBL] [Abstract][Full Text] [Related]
14. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome. Zhao Y; Grambsch PM; Neaton JD Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513 [TBL] [Abstract][Full Text] [Related]
16. Futility approaches to interim monitoring by data monitoring committees. Demets DL Clin Trials; 2006; 3(6):522-9. PubMed ID: 17170036 [TBL] [Abstract][Full Text] [Related]
17. Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent: the diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trial. Lewis RJ; Berry DA; Cryer H; Fost N; Krome R; Washington GR; Houghton J; Blue JW; Bechhofer R; Cook T; Fisher M Ann Emerg Med; 2001 Oct; 38(4):397-404. PubMed ID: 11574796 [TBL] [Abstract][Full Text] [Related]
18. Do clinical trials improve quality of care? A comparison of clinical processes and outcomes in patients in a clinical trial and similar patients outside a trial where both groups are managed according to a strict protocol. West J; Wright J; Tuffnell D; Jankowicz D; West R Qual Saf Health Care; 2005 Jun; 14(3):175-8. PubMed ID: 15933313 [TBL] [Abstract][Full Text] [Related]
19. Preparing the P & T committee agenda for new drug requests. Standish RC; Evans PJ; Bell JE Hosp Formul; 1984 Sep; 19(9):792, 795-800. PubMed ID: 10267929 [TBL] [Abstract][Full Text] [Related]